F and cell surface glycoprotein (GP) that plays an important role in mediating platelet adhesion to the subendothelium after vascular injury.'-8 To date, two receptors for EN on the platelet surface have been identified, the OCJI (GP Ic-IIa) and arrbP3 (GP IIb-IIIa) integrins.'.2 Both receptors recognize the RGD (Arg-Gly-Asp) sequence and adjacent flanking sequences within the cell-binding domain of FN (Fig l ) . 9 9 ' 0 The asPl fibronectin receptor supports adhesion of unactivated platelets to FN, while the (~1&3 receptor binds to FN only after platelet activation.' These receptors, like all members of the integrin family, require divalent cations for ligand binding activity. ' However, recent studies indicate that these two receptors cannot account for all of the physiologically relevant adhesion of platelets to solid-phase FN.3s Nievelstein and Sixma' have presented evidence that platelet adhesion to FN can occur independently of a s~l and aIIbP3 under conditions of flow. Other recently reported resuits are entirely consistent with this conclusion. Piotrowicz et all' have observed that 20% to 40% of total platelet adhesion to FN in a static system is resistant to inhibition by the combined presence of saturating concentrations of inhibitory antibodies directed against the aspl and ~111bP3 integnns. Wayner et all2 have shown that a monoclonal antibody (MoAb) directed against the a5PI integrin produces, at most, a 50% decrement in the adhesion of unactivated platelets to FN. Piotrowicz et all' also observed From the Departments of Medicine, Pathology, and Surgery, Submitted August 27, 1992; accepted November 13. 1992 a large component of divalent cation-independent platelet adhesion to FN that could not be attributed to either of the two FN-binding integrins present on platelets. Our own recent observations have also indicated the presence of a significant divalent cation-independent component of platelet adhesion to FN that is not apparent on substrates of collagen or laminin.13 Collectively, these observations suggest that platelets can adhere to FN by a mechanism distinct from the divalent cation-dependent mechanisms supported by the integrin receptors.
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The purpose of this study was to identify the region of FN that mediates the divalent cation-independent adhesion of platelets to FN. Proteolysis with thermolysin and affinity chromatography were used to isolate the cell-binding, gelatinbinding, and heparin-binding domains of human plasma FN. Adhesion and spreading of both activated and unactivated platelets were characterized on intact FN and its thermolytic fragments in the presence and absence of divalent cations.
The results of these studies indicate that divalent cationindependent adhesion of platelets to FN is mediated by a determinant present in the 45-Kd gelatin-binding fragment. However, only the 105-Kd cell-binding domain of FN supports platelet spreading.
MATERIALS AND METHODS

Materials.
Thermolysin, bovine thrombin, prostaglandin El (PGE,), phenylmethylsulfonylfluoride (PMSF), sodium dodecyl sulfate (SDS), EDTA, leupeptin, and aprotinin were purchased from Sigma Chemical Co (St Louis, MO). Gelatin-Sepharose 4B and heparin-Sepharose CL-6B for affinity chromatography and Sephacryl S-200 for gel filtration were also from Sigma. Polystyrene plates (Falcon no. 1008; Fisher Scientific, St Louis, MO), and four-chamber microscope slides (Lab-Tech, Nunc Inc, Napierville, IL) were used for platelet adhesion assays. Materials for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were purchased from Biorad Laboratories (Richmond, CA). All other materials were reagent grade and purchased from Sigma.
The synthetic peptide RGDSPASSKP was from Penninsula Laboratories (Belmont, CA). KDGEA, as well as control peptides, were synthesized and characterized as previously described.13 The MoAbs L NaCI, 0.025 mol/L Tris, pH 7.4) containing 2.5 mmol/L CaCI2 and incubated with thermolysin (6.0 pglmL) for 5 hours at room temperature. Proteolysis was terminated by the addition of 5.0 mmol/ L EDTA and the digest was applied to a gelatin-Sepharose affinity column (2.5 X 10.0 cm) equilibrated with Tris-buffered saline, (TBS) pH 7.6. Protein fragments bound to gelatin-Sepharose were eluted with 4.0 mol/L urea and dialyzed into TBS. The gelatin-Sepharose eluate was applied to a heparin-Sepharose column (1.0 X 10.0 cm) equilibrated with TBS. This step ensured removal of any fragments with affinity for both heparin and gelatin. The flowthrough contained predominantly a 45-Kd fragment with only gelatin-binding activity. This fragment was further purified by concentration on gelatin-Sepharose, elution with 4.0 mol/L urea, dialysis into TBS, and gel filtration on Sephacryl S-200 (5.0 X 100 cm), allowing separation of the 45-Kd gelatin-binding fragment from trace amounts of smaller and larger gelatin-binding fragments.
Material from the original thermolysin digest that failed to bind gelatin-Sepharose was applied to a heparin-Sepharose affinity column The sequence of thermolytic proteolysis of FN followed by affinity chromatography and gel filtration resulted in the purification of the following proteolytic fragments of FN (Figs 1 and 2 ): the 45-Kd gelatin-binding fragment ("Gel"), the 105-Kd cell-binding fragment containing the RGDS sequence ("Cell"), the 25-Kd low-affinity h e p ann-binding fragment from the N-terminus of FN ("Hep25"). the 30/40-Kd high-affinity heparin-binding fragment from the C-terminus of FN ("Hep30/40"), and the 145/155-Kd fragment containing both the cell-binding and high-affinity heparin-binding domains ("Cell/ Hep").
The purity of intact FN and its thermolytic fragments was confirmed by analysis on 9.5% SDS-PAGE under reducing conditions after the method of Laemmli (Fig 2) : ' In some gels the low-affinity heparin-binding fragment migrated as a 23-and 25-Kd doublet, as originally noted by Sekiguchi and Hakomori (Fig 2) :
' These protein fragments and their M, values were similar to those observed in previous studies in which thermolytic cleavage of human plasma FN was used.'*20 Intact FN and its purified fragments were stored at up to 1.0 mg/mL at -80°C in TBS with 2.0 mol/L urea, 0.02% sodium azide, 2 mmol/L PMSF, 200 Kallikrein inhibitor units (KIU)/mL aprotinin, and 0.1 pg/mL leupeptin. Before use the proteins were thawed and filtered to remove particulates. The fragments were diluted to 50 p d m L with TBS according to the extinction coefficients at 280 nm of lngham et a1."
Reduction and carboxymethylarion of the gelatin-binding domain. The purified gelatin-binding domain (600 pg/mL) in TBS was subjected to reduction with 10.0 mmol/L dithiothreitol (DTT) for I hour at 37°C in a nitrogen atmosphere. The reaction mixture was then made 20.0 mmol/L in iodoacetic acid and incubated for an additional 15 minutes followed by extensive dialysis against TBS in the dark. Human platelets were washed and radiolabeled with "CrO., as previously d e~r i b e d .~' Polystyrene plates were coated for 2 hours at room temperature or overnight at 4°C with 0.5% bovine serum albumin (BSA) in TBS or 50 pg/mL of intact FN or the proteolytic fragments described above. The plates were washed and blocked three times by use of sterile-filtered TBS (0.05 mol/L Tris base, 0.15 mol/L NaCI, pH 7.4) with 0.5% BSA and 0.1% D-glucose (TBSBG). Platelets were suspended at 150,000 to 200,000/pL in TBSBG with either 2.0 mmol/L CaCI2 or 2.0 mmol/ L EDTA, and were permitted to adhere to substrate-coated polystyrene plates for up to 60 minutes at room temperature in the presence of 10 pmol/L PGEl ("unactivated") or 0.5 U/mL of thrombin ("activated"). At the conclusion of the incubation the plates were washed extensively with TBSBG containing Ca2' or EDTA and adherent platelets were lysed with two 1.0-mL aliquots of 2% SDS. The aliquots were pooled and counted in a gamma counter, and the percentage of adherent platelets was determined. All adhesion assays were performed in duplicate.
In some experiments the time of incubation or the concentration of substrate was varied as indicated. In addition, before some platelet adhesion assays the 45-Kd gelatin-binding fragment was first subjected to reduction and carboxymethylation with DTT and iodoacetic acid, or removal of carbohydrate side chains by treatment with endoglycosidase F or PNGase.
In some experiments platelets were preincubated for I5 minutes with 2.0 to 20.0 p d m L of MoAbs against receptors a2p1 (GP la-Ha), as& (GP IC-Ha), a,& (GP Ilbllla), a,&, GP Ib or thrombospondin. Adhesion assays were also performed after preincubation for I5 minutes with synthetic peptides containing the RGDS sequence (100 to 500 pmol/L) recognized by the as& and aid3 integrins or the DGEA
Platelet adhesion assays.
(Asp-Gly-Glu-Ala) sequence (4.0 mmol/L) recognized by the a28, integrin.
Platelet adhesion and spreading were also characterized by performing the above assays on four-chamber microscope slides and photographing the adherent unfixed platelets by use of phase microscopy.
RESULTS
Adhesion assays were performed with washed, SiCr04-labeled platelets on substrates of BSA, intact FN, or the proteolytic fragments of FN (Fig 2) . Figure 3 illustrates the adhesion of unactivated platelets in the presence of 2.0 mmol/L Ca2+ or 2.0 mmol/L EDTA. Under vigorous washing conditions, unactivated platelets adhered to intact FN in both Ca2+ (4.2% & 0.7%) and EDTA (2.8% f 0.6%), whereas adhesion to the BSA control was negligible (50.1%). The cellbinding fragment supported adhesion in the presence ofCa2+ (4.4% f 0.9%), but not EDTA (0.3% f 0.2%). In contrast, adhesion to the gelatin-binding fragment occurred with Ca2+ (3.0% f 0.7%) and even greater adhesion was seen in the presence of EDTA (8.0% f I .2%). The two heparin-binding fragments did not support significant platelet adhesion. Figure 4 illustrates the adhesion of thrombin-activated platelets to intact FN and its proteolytic fragments in the presence of 2.0 mmol/L Ca2+ or 2.0 mmol/L EDTA. Compared with resting platelets, activated platelets showed substantially increased adhesion to intact FN both in the presence of Ca2+ (22.1 % f I .2%) and EDTA ( I 5.4% f 1.1%). Activated platelets adhered to the cell-binding fragment in the presence of Ca2+ (23.3% f I .8%), but EDTA essentially abolished this divalent cationdependent adhesion (3.0% f 0.9%). In contrast, the gelatin-binding fragment supported increased adhesion of activated platelets either in the presence of Ca2+ (21.6% f 1.7%) or EDTA (13.2% f 1.5%). Adhesion to the
bin-activated platelets adhered to both FN and the gelatinbinding fragment but did not spread. The cell-binding fragment did not support adhesion of activated platelets in EDTA (Fig 5) . Qualitatively similar results were obtained with unactivated platelets in EDTA (data not shown).
Both quantitative and morphologic adhesion studies indicated that the cell-binding domain mediates the divalent cation-dependent adhesion and spreading of platelets on intact FN. The gelatin-binding domain accounts for the divalent cation-independent component of platelet adhesion to FN, but does not support platelet spreading (Figs 3 through 5) .
The degree of platelet adhesion to polystyrene plates coated with FN increased with incubation time, temperature, less vigorous washing, platelet activation, and substrate concentration (data not shown). Figure 6 shows that divalent cationindependent adhesion of unactivated platelets to the 45-Kd gelatin-binding domain of FN is both concentration-dependent and saturable. Substrates prepared with 2 5 pg/mL of the 45-Kd gelatin-binding domain supported near-maximal levels of platelet adhesion. The higher level of adhesion observed in this experiment was caused by less vigorous washing, as evidenced by the greater adhesion to BSA (2.8%).
The gelatin-binding domain contains a large number of intrachain disulfide bonds and most of the N-linked carbohydrate of FN. As shown in Fig 7, reduction and carboxymethylation of the 45-Kd gelatin-binding domain with DTT and iodoacetic acid did not impair the ability of this proteolytic fragment to support divalent cation-independent platelet adhesion. SDS-PAGE analysis showed the expected decrease in electrophoretic mobility of the fragment on reduction and carboxymethylation (Fig 7) . In addition, digestion of the 45-Kd gelatin-binding domain with PNGase to remove the car- gelatin-binding fragment by thrombin-activated platelets appeared greater with Ca2+ than EDTA (Fig 4) , which may in part represent a decreased tendency toward platelet aggregate formation after activation in EDTA. However, microscopic examination did not show the presence of significant aggregates.
As in the case of unactivated platelets, thrombin-activated platelets did not adhere to either of the heparin-binding fragments (Fig 4) . The fragment containing the cell-binding and high-affinity heparin-binding fragments ("Cell/Hep") supported adhesion only with activated platelets in the presence of Ca". It is not clear why this fragment failed to support adhesion of unactivated platelets in the presence of Ca2+. Possibly this large fragment is folded in such a way that the RGD and adjacent recognition sequences are not accessible to the as& receptor in unactivated platelets, but are accessible to the all& receptor on thrombin-activated platelets.
The morphology of unactivated and activated platelets adherent to intact FN, the cell-binding domain of FN, and the gelatin-binding domain of FN was examined by phase contrast microscopy. As shown in Fig 5, unactivated platelets in Ca2+ adhered and spread on both intact FN and the cellbinding fragment. The gelatin-binding fragment supported adhesion, but not spreading, of unactivated platelets in Ca2+. Thrombin activation of platelets in Ca2+ increased adhesion of platelets to intact FN, the cell-binding fragment, and the gelatin-binding fragment, but, while thrombin-activated platelets in Ca2' spread extensively on both intact FN and the cell-binding fragment, the gelatin-binding fragment supported only rudimentary spreading (Fig 5) . In EDTA, throm- bohydrate side chains did not alter the ability of this fragment to support divalent cation-independent platelet adhesion ( Fig  8) . SDS-PAGE analysis showed the expected reduction in M, after digestion with PNGase caused by carbohydrate removal (Fig 8) . Results similar to studies with PNGase digestion were obtained with gelatin-binding domain digested with endoglycosidase F (data not shown).
The results of the reduction/carboxymethylation and carbohydrate digestion studies suggest that a linear sequence of amino acids in the 45-Kd gelatin-binding domain of FN interacts in a divalent cation-independent manner with a receptor on the platelet surface (Figs 7 and 8) . Platelet adhesion to this domain appears to be mediated by an as yet uncharacterized platelet receptor. Divalent cation-independent platelet adhesion to the gelatin-binding domain was not prevented by inhibitory MoAbs directed against the G P Ilb-IIla complex (MoAbs 10E5. 7E3. anti-anh&), the vitonectin receptor (MoAb 7E3, anti-cu,lh&. anti-cu&). the cu5/3, integnn (MoAb PID6), the a& integrin (MoAb PIE6), or the GP Ib-IX complex (MoAb 6DI), or by MoAb A2.5 directed against thrombospondin (data not shown). Similarly, adhesion to the 45-Kd fragment was unaltered by the addition of peptides containing the RGDS sequence or the DGEA (a2BI Fibronectin is composed of a series of independent functional domains aligned linearly along the polypeptide chain that are resistant to proteolysis and bind a variety of molecules (Fig l) .' The 45-Kd gelatin-binding domain of FN is a highly conserved region composed of type I and I1 homologous repeats. It has a high carbohydrate content and its gelatin-binding activity requires intact intrachain disulfide This proteolytic fragment does not bind thrombospondin, fibrin(ogen), gangliosides, heparin, or proteoglycans. '
The gelatin-binding activity of FN permitted its purification from plasma and served as the basis of early studies of platelet and fibroblast adhesion and spreading on FN.'*24*2s In later studies proteolytic fragments of FN were used and results indicated that unlike intact FN or the cell-binding fragment, the gelatin-binding fragment did not support fibroblast More recently it was found that nerve cells and lymphocytes do not adhere to the gelatin-binding fragment.'*38.39 These observations together with our findings suggest the presence of a unique platelet-surface receptor that supports adhesion to FN in a divalent cation-independent fashion.
Substantial levels of platelet adhesion to FN in the presence of EDTA have been reported by us and by Piotrowin et all' and Staatz et aI.I3 In the current study we have expanded on these observations by showing that divalent cation-independent adhesion of platelets to FN is mediated solely by the 45-Kd gelatin-binding fragment. Platelet adhesion to this domain can occur in the presence of physiologic concentrations of Ca2+ and is augmented by platelet activation (Fig 4) . As observed in early fibroblast studies, this domain of FN does not support cell spreading (Fig 5) . 
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Although the mechanism of platelet adhesion to the gelatinbinding domain of FN remains to be determined, the ability of platelets to adhere in the absence of divalent cations suggests that integrin receptors are not involved. The data reported here with MoAbs and synthetic peptides directed against known platelet integrins and GP Ib suggest that this adhesion occurs by a novel mechanism. This conclusion is supported by previous work showing that, both under static conditions and conditions of flow, known platelet integrins cannot account for all of platelet adhesion to FN.3v8*"-'3 In addition, because the gelatin-binding domain is not known to bind substances secreted during platelet activation, it is unlikely that adhesion to this domain is mediated by an intermediate ligand.' Furthermore, the adhesion studies using gelatin-binding fragments subjected to reduction and carboxymethylation or carbohydrate digestion suggest that this as yet unknown platelet receptor recognizes a linear sequence of amino acids within the gelatin-binding domain of FN.
Other regions of FN have been reported to support adhesion of some cell types.' These include two sequences (CSI or LDV and REDV) in the alternatively spliced region (V or IIICS) located on the C-terminal side of the high-affinity h e p arin-binding domain of plasma FN (Fig l) .1J*404z
In addition, peptide sequences in the high-affinity heparin domain appear to mediate cell adhesion by binding cell surface heparan sulfate?3 A site within the amino terminal heparin-binding domain is thought to interact with the matrix assembly receptor on fibroblasts and with a macrophage surface protein."*45 However, the present study shows that the heparin-binding domains do not support platelet adhesion (Fig 3) .
We conclude that platelet adhesion to FN is mediated by two domains: the RGD-containing cell-binding domain recognized by the divalent cationdependent integrin receptors as& and ai&,, and the gelatin-binding domain recognized 
